When Antidepressants Stop Working: A New Path Forward with Spravato® in Anaheim, CA

Living with major depressive disorder can feel like an endless cycle of trial and error. You schedule consultations, start a new prescription, and wait six to eight weeks for it to build up in your system—only to experience minimal improvement or frustrating side effects.

If this sounds familiar, you are not out of options, and you are certainly not alone.

Approximately one-third of adults diagnosed with major depression live with Treatment-Resistant Depression (TRD). For individuals across Anaheim and greater Orange County who have found standard medications ineffective, Spravato® (esketamine) offers a scientifically distinct, FDA-approved treatment option administered in a safe, medically supervised setting at Anaheim Community Hospital.

---

What Is Spravato® (Esketamine)?

Spravato® is an FDA-approved nasal spray derived from esketamine, designed specifically for adults who have not found adequate relief through conventional oral antidepressants.

Traditional antidepressants—such as Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)—primarily adjust monoamine neurotransmitters like serotonin, dopamine, or norepinephrine. This process can take weeks or months to produce tangible clinical changes.

Spravato works along an entirely different biological pathway. By acting on NMDA receptors in the brain, it influences the release of glutamate—the brain’s primary excitatory neurotransmitter. This mechanism promotes neuroplasticity, helping to restore and rebuild synaptic connections in areas of the brain that regulate mood, emotional processing, and cognitive function. Because of how it targets these neural pathways, many patients report noticeable symptom reduction within hours or days rather than weeks.

---

Who Qualifies for Spravato Treatment?

Spravato is not a first-line treatment; it is engineered for individuals whose depression has persisted despite standard psychiatric interventions.

If you are unsure whether your medication history qualifies, our clinical team can review your medical records during a complimentary, confidential evaluation.

---

What to Expect During Spravato Treatment at Anaheim Community Hospital

Because Spravato can cause temporary side effects such as drowsiness, sedation, mild dissociation, or elevated blood pressure, it cannot be taken at home. The FDA mandates that it be administered only within a certified Risk Evaluation and Mitigation Strategy (REMS) healthcare facility.

At Anaheim Community Hospital, we prioritize patient comfort, safety, and dignity at every stage of the process:

1. Comfortable, Dedicated Treatment Suites: You will self-administer the nasal spray under the direct guidance of a specialized healthcare professional in a peaceful, low-stimulus room.
2. Two-Hour Monitored Observation: After dosing, you relax in a reclining chair while our clinical nursing team monitors your vital signs, comfort, and well-being for at least two hours.
3. Structured Care Schedule: Treatment typically begins with two sessions per week during the initial induction phase (weeks 1–4). As your symptoms stabilize, visits taper to once weekly and eventually to a bi-weekly maintenance schedule based on your clinical progress.
4. Coordinated Discharge: Because you will not be able to drive immediately following a session, our staff coordinates with your designated driver or caregiver to ensure you return home safely.

---

Is Spravato Covered by Insurance?

One of the most common questions patients ask is whether innovative depression treatments are affordable. Yes, Spravato is covered by most major commercial health insurance plans, as well as Medicare, when clinical criteria for Treatment-Resistant Depression are documented.

Navigating prior authorizations and medical necessity paperwork can feel intimidating, but you do not have to handle it alone. Our intake and insurance verification specialists at Anaheim Community Hospital work directly with your insurer to confirm benefits, obtain authorizations, and explore copay assistance programs (such as manufacturer savings cards) to minimize out-of-pocket costs.

---

Frequently Asked Questions About Spravato

How is Spravato different from IV ketamine infusions?

While both involve related compounds that target NMDA receptors, Spravato (esketamine) is the S-enantiomer of ketamine and is FDA-approved specifically for Treatment-Resistant Depression. IV ketamine is used off-label for psychiatric conditions and is rarely covered by commercial insurance, requiring significant out-of-pocket payment. Spravato is an intranasal spray, non-invasive, and broadly recognized by private insurance and Medicare.

How quickly does Spravato start working?

Unlike oral antidepressants that take four to eight weeks to alter neurotransmitter levels, clinical studies show that many individuals receiving Spravato experience symptom reduction within the first 24 to 48 hours following their initial sessions.

Where is the Spravato clinic located?

Our certified Spravato clinic is located on-site at Anaheim Community Hospital in Anaheim, California, conveniently serving residents across North Orange County, including Buena Park, Fullerton, Garden Grove, Cypress, and surrounding communities.

---